XML 16 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY - USD ($)
Total
Common stock
Capital in excess of par value
Retained earnings
Accumulated  other comprehensive (loss) income
Treasury stock
Non-controlling interest
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjustment
Retained earnings
Beginning Balance at Dec. 31, 2018 $ 6,043,374,000 $ 16,066,000 $ 3,793,609,000 $ 3,956,221,000 $ (702,227,000) $ (1,030,718,000) $ 10,423,000    
Beginning Balance (Accounting Standards Update 2016-02) at Dec. 31, 2018               $ 23,094,000 $ 23,094,000
Beginning Balance (Accounting Standards Update 2017-12) at Dec. 31, 2018               $ 981,000 $ 981,000
Beginning Balance, shares at Dec. 31, 2018           21,906,935      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 246,712,000     245,206,000     1,506,000    
Cumulative translation adjustment 28,363,000       28,363,000        
Gains (losses) on derivatives qualifying as hedges; net of tax 318,000       318,000        
Pension and postretirement net liability 5,187,000       5,187,000        
Cash dividends declared (155,703,000)     (155,703,000)          
Stock options/SSARs 5,746,000   5,085,000     $ 661,000      
Stock options, shares           14,002      
Vested restricted stock units and awards (4,333,000)   (10,968,000)     $ 6,635,000      
Vested restricted stock units and awards, shares           141,096      
Stock-based compensation 18,300,000   18,300,000            
Redeemable NCI (143,000)   (143,000)            
Dividends paid on noncontrolling interest and Other (1,909,000)     (588,000)     (1,321,000)    
Ending Balance at Jun. 30, 2019 6,209,987,000 16,066,000 3,805,883,000 4,069,211,000 (668,359,000) $ (1,023,422,000) 10,608,000    
Ending Balance, shares at Jun. 30, 2019           21,751,837      
Beginning Balance at Mar. 31, 2019 6,154,478,000 16,066,000 3,802,602,000 4,011,326,000 (657,354,000) $ (1,029,429,000) 11,267,000    
Beginning Balance, shares at Mar. 31, 2019           21,879,556      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 137,039,000     136,377,000     662,000    
Cumulative translation adjustment (14,014,000)       (14,014,000)        
Gains (losses) on derivatives qualifying as hedges; net of tax 415,000       415,000        
Pension and postretirement net liability 2,594,000       2,594,000        
Cash dividends declared (77,904,000)     (77,904,000)          
Stock options/SSARs 1,662,000   1,661,000     $ 1,000      
Stock options, shares           24      
Vested restricted stock units and awards (2,557,000)   (8,563,000)     $ 6,006,000      
Vested restricted stock units and awards, shares           127,695      
Stock-based compensation 10,696,000   10,696,000            
Redeemable NCI (513,000)   (513,000)            
Dividends paid on noncontrolling interest and Other (1,909,000)     (588,000)     (1,321,000)    
Ending Balance at Jun. 30, 2019 6,209,987,000 16,066,000 3,805,883,000 4,069,211,000 (668,359,000) $ (1,023,422,000) 10,608,000    
Ending Balance, shares at Jun. 30, 2019           21,751,837      
Beginning Balance at Dec. 31, 2019 $ 6,229,548,000 16,066,000 3,823,152,000 4,117,804,000 (716,894,000) $ (1,022,824,000) 12,244,000    
Beginning Balance, shares at Dec. 31, 2019 (21,738,838)         21,738,838      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income $ 212,219,000     210,811,000     1,408,000    
Cumulative translation adjustment (305,810,000)       (305,810,000)        
Gains (losses) on derivatives qualifying as hedges; net of tax (1,654,000)       (1,654,000)        
Pension and postretirement net liability 6,892,000       6,892,000        
Cash dividends declared (160,235,000)     (160,235,000)          
Stock options/SSARs 1,474,000   (1,249,000)     $ 2,723,000      
Stock options, shares           57,228      
Vested restricted stock units and awards (4,057,000)   (6,938,000)     $ 2,881,000      
Vested restricted stock units and awards, shares           87,513      
Stock-based compensation 18,982,000   18,982,000            
Redeemable NCI 4,100,000   4,100,000            
Dividends paid on noncontrolling interest and Other (543,000)     (2,000)     (541,000)    
Ending Balance at Jun. 30, 2020 $ 6,000,916,000 16,066,000 3,838,047,000 4,168,378,000 (1,017,466,000) $ (1,017,220,000) 13,111,000    
Ending Balance, shares at Jun. 30, 2020 (21,713,880)         21,594,097      
Beginning Balance at Mar. 31, 2020 $ 5,840,674,000 16,066,000 3,835,265,000 4,162,347,000 (1,164,208,000) $ (1,021,620,000) 12,824,000    
Beginning Balance, shares at Mar. 31, 2020           21,713,880      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 86,995,000     86,204,000     791,000    
Cumulative translation adjustment 146,468,000       146,468,000        
Gains (losses) on derivatives qualifying as hedges; net of tax (3,101,000)       (3,101,000)        
Pension and postretirement net liability 3,375,000       3,375,000        
Cash dividends declared (80,173,000)     (80,173,000)          
Stock options/SSARs 1,292,000   (759,000)     $ 2,051,000      
Stock options, shares           43,465      
Vested restricted stock units and awards (2,762,000)   (5,111,000)     $ 2,349,000      
Vested restricted stock units and awards, shares           76,318      
Stock-based compensation 10,358,000   10,358,000            
Redeemable NCI (1,706,000)   (1,706,000)            
Dividends paid on noncontrolling interest and Other (504,000)                
Ending Balance at Jun. 30, 2020 $ 6,000,916,000 $ 16,066,000 $ 3,838,047,000 $ 4,168,378,000 $ (1,017,466,000) $ (1,017,220,000) $ 13,111,000    
Ending Balance, shares at Jun. 30, 2020 (21,713,880)         21,594,097